Medicare Enrolled
Dr. Lisa Casale, M.D.
Internal Medicine · Edison, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Casale from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Casale?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Casale
Dr. Lisa Casale is an internal medicine specialist in Edison, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Casale performed 2,604 Medicare services across 1,537 unique beneficiaries.
Between the years covered by Open Payments, Dr. Casale received a total of $8,961 from 40 pharmaceutical and/or device companies across 513 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Casale is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 16% volume in NJ
$8,961 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,604
Medicare services
Top 16% in NJ for internal medicine
1,537
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~137 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
515 | $106 | $235 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
329 | $70 | $183 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
313 | $24 | $114 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
243 | $184 | $560 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
223 | $108 | $241 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
219 | $148 | $323 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
96 | $151 | $466 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
93 | $40 | $340 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
93 | $51 | $137 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
83 | $36 | $155 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
69 | $43 | $299 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
59 | $35 | $216 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
50 | $16 | $90 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
41 | $47 | $271 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
35 | $74 | $178 |
| New patient office visit, complex (60-74 min) | 34 | $169 | $425 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
34 | $16 | $121 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
33 | $8 | $35 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
25 | $94 | $400 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
17 | $113 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,961
Total received (2018-2024)
Avg $1,280/year across 7 years
Top 9% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
513
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,840 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$121 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,873
2023
$2,356
2022
$1,450
2021
$1,134
2020
$306
2019
$857
2018
$984
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$467
GlaxoSmithKline, LLC.
$466
Philips North America LLC
$273
Inspire Medical Systems, Inc.
$169
Mylan Specialty L.P.
$148
Amgen Inc.
$110
Insmed, Inc.
$82
Boehringer Ingelheim Pharmaceuticals, Inc.
$46
Regeneron Healthcare Solutions, Inc.
$32
Baxter Healthcare
$27
ANI Pharmaceuticals, Inc.
$19
GENZYME CORPORATION
$17
Azurity Pharmaceuticals, Inc.
$15
Top 3 companies account for 64.4% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$3,078
AstraZeneca Pharmaceuticals LP
$1,695
Boehringer Ingelheim Pharmaceuticals, Inc.
$538
Mylan Specialty L.P.
$437
Amgen Inc.
$436
Inspire Medical Systems, Inc.
$334
Electromed, Inc.
$309
Philips Electronics North America Corporation
$278
Philips North America LLC
$273
Insmed, Inc.
$256
E.R. Squibb & Sons, L.L.C.
$131
Regeneron Healthcare Solutions, Inc.
$130
CSL Behring
$121
GENZYME CORPORATION
$112
Sunovion Pharmaceuticals Inc.
$98
Merck Sharp & Dohme Corporation
$95
Shire North American Group Inc
$55
Grifols USA, LLC
$54
Janssen Pharmaceuticals, Inc
$53
Genentech USA, Inc.
$50
Takeda Pharmaceuticals U.S.A., Inc.
$46
PFIZER INC.
$43
Mallinckrodt Hospital Products Inc.
$28
Circassia Pharmaceuticals Inc
$28
Baxter Healthcare
$27
Pulmonx Corporation
$26
Advanced Respiratory, Inc
$25
Covidien LP
$22
ANI Pharmaceuticals, Inc.
$19
Axsome Therapeutics, Inc.
$16
BOSTON SCIENTIFIC CORPORATION
$16
Resmed Corp
$16
Azurity Pharmaceuticals, Inc.
$15
Jazz Pharmaceuticals Inc.
$15
Mallinckrodt Enterprises LLC
$15
Novartis Pharmaceuticals Corporation
$15
JAZZ PHARMACEUTICALS INC.
$15
Allergan Inc.
$15
Mallinckrodt LLC
$14
Optinose US, Inc.
$13
Top 3 companies account for 59.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · AVYCAZ · AirSense · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · CAMZYOS · CHANTIX · CHARTIS CATHETER · DUPIXENT · Dymista · ELIQUIS · FARXIGA · FASENRA · GENERAL PULMONARY · GLASSIA · HORIZANT · Hillrom - Life 2000 Ventilation System · INSPIRE · LONHALA MAGNAIR · NUCALA · OFEV · PAXLOVID · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Prolastin-C Liquid · SHINGRIX · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · The Vest System Model 105 Home Care · UTIBRON NEOHALER · XARELTO · XOLAIR · Xhance · Xolair · YUPELRI · Yupelri · ZERBAXA · Zemaira · superDimension
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for internal medicine in NJ.
Geographic Context
Internal medicine physicians within 10 mi
6,027
Per 100K population
699.6
County median income
$109,028
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT RAHWAY
4.9 mi
4.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Casale is a clinical cardiology specialist, with above-average Medicare volume (top 16% in NJ), with low-engagement industry engagement in the top 9% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Casale experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Casale performed 515 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Casale receive payments from pharmaceutical companies?
Yes. Dr. Casale received a total of $8,961 from 40 companies across 513 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Casale's costs compare to other internal medicine physicians in Edison?
Dr. Casale's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Casale) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Edison
Browse internal medicine physicians in Edison ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology